NIR‐II D–A–D‐Type Small‐Molecule Coordination with Carboxylatopillar[5]Arene: a Multifunctional Phototheranostic for Low‐Temperature NIR‐II Photothermal/Platinum‐Based/Chemodynamic Combination Cancer Immunotherapy
Small · 2025
DOI: 10.1002/smll.202501903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Miaomiao Ding und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Weny…. Hauptthemen laut MEDLINE: Immunotherapy, Platinum, Infrared Rays, Photothermal Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic Research Program of Jiangsu, Natural Science Foundation of Nanjing University of Posts and Telecommunications.
Abstract (Originalsprache)
Low‐temperature second near‐infrared region (NIR‐II) photothermal therapy (PTT) has shown significant potential in minimizing damage to normal tissues and reducing inflammation. However, it still faces challenge of insufficient immune response. Thus, a multifunctional phototheranostic nanoparticle (BDPB/Pt/Fe@P[5]) is developed by co‐loading BDPB, CDHPt, and Fe 2 ⁺ with a pH‐sensitive lipid DSPE‐PEOz2K. The carboxylatopillar[5]arene (CP[5]) used to construct this nanoparticle exhibits strong host–guest recognition with pyridine salts, alleviating aggregation caused quench (ACQ) effect and enhancing the NIR‐II emission of the donor–acceptor–donor (D–A–D)‐type organic small molecule (BDPB). CP[5] provides suitable vehicles for encapsulating platinum (IV) prodrugs (CDHPt) and Fe 2 ⁺ ions via metal coordination for controllable reactive oxygen species (ROS) release. Under low‐intensity NIR‐II laser irradiation and an acidic tumor microenvironment, the nanoparticles degrade, releasing CDHPt and Fe 2 ⁺ ions for platinum‐based therapy and chemodynamic therapy (CDT). CDHPt facilitates the direct production of superoxide anions (O₂·⁻) from O₂ and partially converts it into the highly cytotoxic hydroxyl radicals, thereby promoting the Fenton reaction process. The therapeutic efficacy is further synergized by immunogenic cell death (ICD) effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing, 210023, China.
- Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
- College of Chemistry and Chemical Engineering, Xinyang Normal University, Xinyang, Henan, 464000, China.
ORCID-Profile: Pengfei Sun, Daifeng Li, Quli Fan
Förderung
- National Natural Science Foundation of China
- Basic Research Program of Jiangsu
- Natural Science Foundation of Nanjing University of Posts and Telecommunications
Zitieren
APA
Ding, M., Chen, H., He, L., Wang, Z., Zhao, X., Sun, P., Mei, Q., Li, D., & Fan, Q. (2025). NIR‐II D–A–D‐Type Small‐Molecule Coordination with Carboxylatopillar[5]Arene: a Multifunctional Phototheranostic for Low‐Temperature NIR‐II Photothermal/Platinum‐Based/Chemodynamic Combination Cancer Immunotherapy. Small. https://doi.org/10.1002/smll.202501903
Vancouver
Ding M, Chen H, He L, Wang Z, Zhao X, Sun P, et al. NIR‐II D–A–D‐Type Small‐Molecule Coordination with Carboxylatopillar[5]Arene: a Multifunctional Phototheranostic for Low‐Temperature NIR‐II Photothermal/Platinum‐Based/Chemodynamic Combination Cancer Immunotherapy. Small. 2025. doi:10.1002/smll.202501903
BibTeX
@article{Ding2025,
author = {Ding, Miaomiao and Chen, Haoran and He, Liuliang and Wang, Zhichao and Zhao, Xianghua and Sun, Pengfei and Mei, Qunbo and Li, Daifeng and Fan, Quli},
title = {NIR‐II D–A–D‐Type Small‐Molecule Coordination with Carboxylatopillar[5]Arene: a Multifunctional Phototheranostic for Low‐Temperature NIR‐II Photothermal/Platinum‐Based/Chemodynamic Combination Cancer Immunotherapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202501903}
}
EUVIMED